Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C
Authors
Keywords
Apoptosis inhibitor of macrophage, Adipocytokine, Hepatic fibrosis, Hepatitis C virus, Chronic hepatitis, Insulin resistance
Journal
BMC GASTROENTEROLOGY
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-02-14
DOI
10.1186/1471-230x-14-27
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes
- (2012) Yoshihiro Iwamura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients
- (2012) Mayu Ohnishi et al. JOURNAL OF GASTROENTEROLOGY
- Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis
- (2011) Jeffrey A. Handy et al. BIOCHEMICAL JOURNAL
- Selection of the appropriate method for the assessment of insulin resistance
- (2011) Anwar Borai et al. BMC Medical Research Methodology
- AIMing at Metabolic Syndrome
- (2011) Toru Miyazaki et al. CIRCULATION JOURNAL
- Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy
- (2011) Yoshito Itoh et al. HEPATOLOGY RESEARCH
- Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue
- (2011) J. Kurokawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis
- (2009) Arzu Tiftikci et al. ARCHIVES OF MEDICAL RESEARCH
- A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease
- (2009) Joe Gray et al. BMC CANCER
- Adipokines in liver diseases
- (2009) Fabio Marra et al. HEPATOLOGY
- Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C
- (2008) Ian Homer Y. Cua et al. HEPATOLOGY
- Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
- (2008) Donna L. White et al. JOURNAL OF HEPATOLOGY
- Unknown
- (2008) Katja Rabe et al. MOLECULAR MEDICINE
- Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity
- (2008) Emmanuel Tsochatzis et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis
- (2007) Rami Moucari et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now